0.55 (-%)
As of Nov 21, 2024
Source:
Nexalin Technology, Inc. design and develop innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. We developed an easy-to-administer medical device — referred to as Generation 1 or Gen-1 — that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy.
Country | United States |
Headquarters | houston, texas |
Phone Number | (832) 260-0222 |
Industry | |
CEO | Mark White |
Website | www.nexalin.com |